Intestinal adaptations following bariatric surgery: towards the identification of new pharmacological targets for obesity-related metabolic diseases

被引:4
|
作者
Ribeiro-Parenti, Lara [1 ]
Cavin, Jean-Baptiste [1 ,2 ]
Le Gall, Maude [1 ]
机构
[1] Univ Paris Diderot, Sorbonne Paris Cite, DHU Unity APHP, UFR Med Paris Diderot,Inserm UMR 1149, F-75890 Paris, France
[2] Univ Calgary, Hotchkiss Brain Inst, Dept Physiol & Pharmacol, Calgary, AB T2N 4N1, Canada
关键词
Y GASTRIC BYPASS; GLUCAGON-LIKE PEPTIDE-1; HUMAN GUT MICROBIOTA; WEIGHT-LOSS; SLEEVE GASTRECTOMY; GLUCOSE-METABOLISM; BLOOD-GLUCOSE; IMPROVEMENT; METFORMIN; RATS;
D O I
10.1016/j.coph.2017.08.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Although the gastrointestinal tract is the primary target of bariatric surgery, its contributions to the metabolic changes observed after surgery are still underestimated. Changes in the number of incretin-producing cells could result in the modified hormonal response seen after surgery. Additionally, the rate of absorption and consumption of glucose could contribute to the ameliorated glycaemia. Moreover, decreased intestinal permeability could prevent endotoxemia.Recently, numerous studies have focused on intestinal adaptation following bariatric surgeries. These studies bring new insight into the different roles the GI tract plays in the metabolic outcomes of bariatric surgery and open new avenues for therapeutic treatments.
引用
收藏
页码:29 / 34
页数:6
相关论文
共 19 条
  • [1] The Impact of Bariatric Surgery on Childhood Obesity-Related Metabolic Disorders Preface
    Teich, Steven
    Michalsky, Marc P.
    SEMINARS IN PEDIATRIC SURGERY, 2009, 18 (03) : 125 - 125
  • [2] Objective Assessment of Obesity-Related Comorbidity Resolution Following Bariatric Surgery
    Liu, J. X.
    Saunders, J. K.
    Parikh, M.
    OBESITY SURGERY, 2011, 21 (08) : 1027 - 1028
  • [3] Can Bariatric and Metabolic Surgery Prevent Cancer Recurrence in Obesity-Related Neoplasms?
    Sonja Chiappetta
    Vincenzo Bottino
    Amalia Farina
    Obesity Surgery, 2022, 32 : 3469 - 3470
  • [4] Can Bariatric and Metabolic Surgery Prevent Cancer Recurrence in Obesity-Related Neoplasms?
    Chiappetta, Sonja
    Bottino, Vincenzo
    Farina, Amalia
    OBESITY SURGERY, 2022, 32 (10) : 3469 - 3470
  • [5] Resmetirom and Bariatric Surgery: New Frontiers in Treating Obesity-Related Metabolic Dysfunction-Associated Steatohepatitis
    Au, Kahei
    Yang, Wah
    OBESITY SURGERY, 2024, 34 (09) : 3525 - 3526
  • [6] Is butyrate the link between diet, intestinal microbiota and obesity-related metabolic diseases?
    Brahe, L. K.
    Astrup, A.
    Larsen, L. H.
    OBESITY REVIEWS, 2013, 14 (12) : 950 - 959
  • [7] Attacking obesity-related diseases at the source - Is bariatric surgery the next wave in cancer prevention?
    Argenta, Peter A.
    GYNECOLOGIC ONCOLOGY, 2017, 145 (02) : 219 - 220
  • [8] New mechanisms and the anti-inflammatory role of curcumin in obesity and obesity-related metabolic diseases
    Adeeb Shehzad
    Taewook Ha
    Fazli Subhan
    Young Sup Lee
    European Journal of Nutrition, 2011, 50 : 151 - 161
  • [9] New mechanisms and the anti-inflammatory role of curcumin in obesity and obesity-related metabolic diseases
    Shehzad, Adeeb
    Ha, Taewook
    Subhan, Fazli
    Lee, Young Sup
    EUROPEAN JOURNAL OF NUTRITION, 2011, 50 (03) : 151 - 161
  • [10] Obesity-related renal dysfunction: gender-specific influence of visceral adiposity and early impact of metabolic and bariatric surgery
    Popa, Miruna Maria
    Sirbu, Anca Elena
    Malinici, Elisabeta Andreea
    Copaescu, Catalin
    Fica, Simona
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15